Brief: Vital KSK Holdings Inc - Conclusion Of Exclusive License Agreement Of Shield Therapeutics PLC's Iron Deficiency Treatment By Consolidated Subsidiary
22/04/2025 06:32
April 22 (Reuters) - Vital KSK Holdings Inc 3151.T: NOTICE OF CONCLUSION OF EXCLUSIVE LICENSE AGREEMENT OF SHIELD THERAPEUTICS PLC'S IRON DEFICIENCY TREATMENT BY CONSOLIDATED SUBSIDIARY Source text: ID:nTSpv7f01e Further company coverage: 3151.T